Lebenthal Global Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Lebenthal Global Advisors's LLY Position: Q1 2026 in Review
Lebenthal Global Advisors increased its Eli Lilly (LLY) stake by 31% in Q1 2026, buying an estimated $1.34M and bringing the position to 5,597 shares worth $5.15M. The position accounts for 0.75% of the portfolio, ranked #26.
Lebenthal Global Advisors first reported a position in LLY in Q4 2020 and has held it in 17 quarters since. The position peaked at $5.35M in Q3 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Lebenthal Global Advisors held 5,597 shares of Eli Lilly worth $5.15M as of Q1 2026.
- Lebenthal Global Advisors bought 1,320 Eli Lilly shares in Q1 2026, an estimated $1.34M.
- Eli Lilly made up 0.75% of Lebenthal Global Advisors's portfolio in Q1 2026, its #26 holding.
- Lebenthal Global Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 17 quarters since.
- Lebenthal Global Advisors's Eli Lilly position peaked at $5.35M in Q3 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.